The epidemiology of carbapenemases in Latin America and the Caribbean
Cargando...
Fecha
Título de la revista
Publicado en
Expert review of anti-infective therapy, 1744-8336, Vol. 15, Nro. 3, 2017, p. 277-297
Publicado por
Taylor & Francis
URL de la fuente
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. infections are major causes of morbidity and mortality, especially due to the emergence and spread of β-lactamases. Carbapenemases, which are β-lactamases with the capacity to hydrolyze or inactivate carbapenems, have become a serious concern as they have the largest hydrolytic spectrum and therefore limit the utility of most β-lactam antibiotics. Areas covered: Here, we present an update of the current status of carbapenemases in Latin America and the Caribbean. Expert commentary: The increased frequency of reports on carbapenemases in Latin America and the Caribbean shows that they have successfully spread and have even become endemic in some countries. Countries such as Brazil, Colombia, Argentina, and Mexico account for the majority of these reports. Early suspicion and detection along with implementation of antimicrobial stewardship programs in all healthcare settings are crucial for the control and prevention of carbapenemase-producing bacteria.
Palabras clave
Keywords
Carbapenemases, β-lactamases, Carbapenems, Enterobacteriaceae
Temáticas
Pseudomonas aeruginosa
Acinetobacter baumannii
Farmacorresistencia bacteriana
Acinetobacter baumannii
Farmacorresistencia bacteriana